Literature DB >> 12190156

Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.

Benjamin Avidan1, Amnon Sonnenberg, Thomas G Schnell, Gregorio Chejfec, Adrienne Metz, Stephen J Sontag.   

Abstract

OBJECTIVE: The reasons for the development of dysplasia and adenocarcinoma in Barrett's mucosa are not well understood. The aims of this study were to characterize risk factors for the transition from Barrett's esophagus without dysplasia to Barrett's esophagus with high-grade dysplasia or esophageal adenocarcinoma.
METHODS: A group of 131 patients with high-grade dysplasia or esophageal adenocarcinoma were selected as case subjects. A first population of 2170 patients without gastroesophageal reflux disease (GERD) and a second population of 1189 patients with Barrett's esophagus served as two control groups. Logistic regression analyses were used to compare the risk factors associated with the occurrence of high-grade dysplasia or esophageal adenocarcinoma.
RESULTS: Patients with high-grade dysplasia or esophageal adenocarcinoma shared many characteristics with other forms of severe GERD, such as older age, male gender, and white ethnicity. The length of Barrett's esophagus and the size of hiatus hernia increased the risk for both conditions. Subjects with high-grade dysplasia and adenocarcinoma had more severe acid reflux than patients with other forms of GERD. Smoking and alcohol consumption did not affect the risk for developing high-grade dysplasia or adenocarcinoma in patients with Barrett's esophagus.
CONCLUSIONS: High-grade dysplasia and esophageal adenocarcinoma seem to stem from an extreme and unfavorable constellation of all risk factors that are generally held responsible for the development of GERD and Barrett's esophagus.

Entities:  

Mesh:

Year:  2002        PMID: 12190156     DOI: 10.1111/j.1572-0241.2002.05902.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  68 in total

1.  [Barrett esophagus: ablative methods of treatment].

Authors:  M Jung; C Ell
Journal:  Internist (Berl)       Date:  2003-01       Impact factor: 0.743

2.  Increased expression of VEGF, COX-2, and Ki-67 in Barrett's esophagus: does the length matter?

Authors:  Evanthia Zampeli; George Karamanolis; George Morfopoulos; Elias Xirouchakis; Vasiliki Kalampoki; Spyros Michopoulos; Sotiria Savva; Vasilios Tzias; Irene Zouboulis-Vafiadis; Dimitrios Kamberoglou; Spiros D Ladas
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

Review 3.  Risk factors for neoplastic progression in Barrett's esophagus.

Authors:  Elizabeth F Wiseman; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

Review 4.  Barrett's esophagus: Clinical issues.

Authors:  Stuart Jon Spechler
Journal:  Gastrointest Endosc Clin N Am       Date:  2011-01

5.  Laparoscopic treatment of Barrett's esophagus: long-term results.

Authors:  L Biertho; B Dallemagne; J-M Dewandre; C Jehaes; S Markiewicz; B Monami; C Wahlen; J Weerts
Journal:  Surg Endosc       Date:  2006-11-16       Impact factor: 4.584

6.  Increased Barrett's esophagus for the decade between 1991 and 2000 at a single university medical center.

Authors:  Shayan Irani; Henry P Parkman; Rebecca Thomas; Benjamin Krevsky; Robert S Fisher; Peter Axelrod
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

7.  Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.

Authors:  L A García Rodríguez; J Lagergren; M Lindblad
Journal:  Gut       Date:  2006-06-19       Impact factor: 23.059

Review 8.  Surgical management of esophagogastric junction tumors.

Authors:  Burkhard H A von Rahden; Hubert J Stein; J Rüdiger Siewert
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

9.  Elevated serum gastrin is associated with a history of advanced neoplasia in Barrett's esophagus.

Authors:  Judy S Wang; Andrea Varro; Charles J Lightdale; Nantaporn Lertkowit; Kristen N Slack; Michael L Fingerhood; Wei Yann Tsai; Timothy C Wang; Julian A Abrams
Journal:  Am J Gastroenterol       Date:  2009-11-10       Impact factor: 10.864

10.  Gallstones increase the prevalence of Barrett's esophagus.

Authors:  Juntaro Matsuzaki; Hidekazu Suzuki; Keiko Asakura; Yoshimasa Saito; Kenro Hirata; Toru Takebayashi; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2009-11-12       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.